Urgent Field Safety Notice for Quantum Blue Adalimumab by Bühlmann Laboratories AG
2021.12.03
Product group In-vitro diagnostics - immunological products
Reference 27501/21
For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.